(Q70549049)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8428390%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

title

Prevention of cyclophosphamide-induced diabetes in the NOD/WEHI mouse with deoxyspergualin (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8428390%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8428390%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

2

M O Borghi

1 reference

12 October 2019

4

W Barcellini

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8428390%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

author name string

F Nicoletti

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8428390%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

C Fain

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8428390%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

R Di Marco

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8428390%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

R Menta

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8428390%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

H U Schorlemmer

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8428390%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

G Bruno

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8428390%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

G Magro

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8428390%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

publication date

1 February 1993

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8428390%20AND%20SRC:MED&resulttype=core&format=json

Clinical and Experimental Immunology

12 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8428390%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

volume

91

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8428390%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8428390%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

page(s)

232-236

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8428390%20AND%20SRC:MED&resulttype=core&format=json

Essential role for interferon-gamma and interleukin-6 in autoimmune insulin-dependent diabetes in NOD/Wehi mice

12 October 2019

cites work

1 reference

12 December 2020

FK 506: an immunosuppressant for the 1990s?

1 reference

12 December 2020

Fusidic acid, an immunosuppressive drug with functions similar to cyclosporin A

1 reference

12 December 2020

Effects of FK506, 15-deoxyspergualin, and cyclosporine on experimental autoimmune uveoretinitis in the rat.

1 reference

12 December 2020

FK-506 prevents diabetes in diabetes-prone BB/Wor rats

1 reference

12 December 2020

Effects of Ginkgolide B, A Platelet-Activating Factor Inhibitor on Insulitis in the Spontaneously Diabetic Bb Rat

1 reference

12 December 2020

The spectrum of action of new immunosuppressive drugs

1 reference

12 December 2020

Distribution of interferon-gamma receptor in human tissues

1 reference

12 December 2020

The effects of deoxyspergualin on the development of diabetes in diabetes-prone BB rats

1 reference

12 December 2020

In vitro immunosuppressive effect: a comparative study between deoxymethylspergualin and cyclosporin A, on human lymphocyte responses

1 reference

12 December 2020

High and Low Diabetes Incidence Nonobese Diabetic (NOD) Mice: Origins and Characterisation

1 reference

12 December 2020

A new antitumor antibiotic, spergualin: Isolation and antitumor activity

1 reference

12 December 2020

The murine IL 2 receptor. I. Monoclonal antibodies that define distinct functional epitopes on activated T cells and react with activated B cells

1 reference

12 December 2020

Suppression of macrophage function and prolongation of graft survival by the new guanidinic-like structure, 15-deoxyspergualin

1 reference

12 December 2020

Prolongation of rat heart allograft survival by 15-deoxyspergualin

1 reference

12 December 2020

Immunosuppressive activities of deoxyspergualin. I. Effect of the long-term administration of the drug on the development of murine lupus

1 reference

12 December 2020

Administration of silica particles or anti-Lyt2 antibody prevents beta-cell destruction in NOD mice given cyclophosphamide

1 reference

12 December 2020

Mechanisms of autoimmunity in insulin-dependent diabetes mellitus.

1 reference

12 December 2020

The majority of the activated T cells in the blood of insulin-dependent diabetes mellitus (IDDM) patients are CD4+

1 reference

12 December 2020

Therapeutic effect of 15-deoxyspergualin on acute graft rejection detected by 31P nuclear magnetic resonance spectrography, and its effect on rat heart transplantation.

1 reference

12 December 2020

Ly-6C is a monocyte/macrophage and endothelial cell differentiation antigen regulated by interferon-gamma

1 reference

12 December 2020

Cyclophosphamide-induced diabetes in NOD/WEHI mice. Evidence for suppression in spontaneous autoimmune diabetes mellitus

1 reference

12 December 2020

The role of interleukin 2 in autoimmunity

1 reference

12 December 2020

Mechanism of action of 15-deoxyspergualin. I. Suppressive effect on the induction of alloreactive secondary cytotoxic T lymphocytes in vivo and in vitro

1 reference

12 December 2020

Prevention of cyclophosphamide-induced diabetes by anti-V beta 8 T-lymphocyte-receptor monoclonal antibody therapy in NOD/Wehi mice

1 reference

12 December 2020

Effects of deoxyspergualin on collagen arthritis in mice

1 reference

12 December 2020

Prevention of diabetes in BB/Wor rats treated with monoclonal antibodies to interferon-gamma

1 reference

12 December 2020

15-Deoxyspergualin for induction of graft nonreactivity after cardiac and renal allotransplantation in primates

1 reference

12 December 2020

Prevention of spontaneous diabetes in BB rats with FK 506

1 reference

12 December 2020

Therapeutic effect of 15-deoxyspergualin on the progression of lupus nephritis in MRL mice. I. Immunopathological analyses

1 reference

12 December 2020

Preventive effect of a new immunosuppressant FK-506 on insulitis and diabetes in non-obese diabetic mice

1 reference

12 December 2020

Toxicological and immunological evaluation of the immunosuppressant 15-deoxyspergualin in BALB/c mice: an in vivo and in vitro study

1 reference

12 December 2020